癌变·畸变·突变 ›› 2015, Vol. 27 ›› Issue (3): 168-171,176.doi: 10.3969/j.issn.1004-616x.2015.03.002

• 论著 • 上一篇    下一篇

SOX30基因在结直肠癌中的表达与甲基化分析

史荣辉, 韩飞, 董严, 张明谦, 姜晓, 尹俐, 刘文斌, 曹佳, 刘晋祎   

  1. 第三军医大学军事预防医学院毒理学研究所, 重庆 400038
  • 收稿日期:2015-02-26 修回日期:2015-05-06 出版日期:2015-05-30 发布日期:2015-05-30
  • 通讯作者: 刘晋祎,E-mail:jinyiliutmmu@163.com E-mail:jinyiliutmmu@163.com
  • 作者简介:史荣辉,E-mail:00011043@163.com
  • 基金资助:

    国家自然科学基金项目(81172714)

The expression and methylation of SOX30 gene in colorectal cancer

SHI Ronghui, HAN Fei, DONG Yan, ZHANG Mingqian, JIANG Xiao, YIN Li, LIU Wenbin, CAO Jia, LIU Jinyi   

  1. Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China
  • Received:2015-02-26 Revised:2015-05-06 Online:2015-05-30 Published:2015-05-30

摘要:

目的:探讨新发现的抑癌基因SRY盒包含基因30(SOX30)在结直肠癌中的表达及甲基化变化。方法:用逆转录PCR(RT-PCR)检测结直肠癌细胞株(HCT8、HCT116和SW480)中SOX30 mRNA的表达,利用去甲基化药物5-Aza-CdR处理结直肠癌细胞株72 h后检测SOX30基因高甲基化与其表达调控的关系。应用甲基化特异性PCR(MSP)检测上述3株结直肠癌细胞株及54例结直肠肿瘤组织和10例癌旁组织SOX30基因的甲基化发生情况,通过硫化测序PCR(BSP)验证结直肠癌组织和癌旁组织SOX30基因的甲基化改变,并对甲基化情况与结直肠癌患者病理特征进行相关性分析。结果:SOX30 mRNA在上述3株结直肠癌细胞株中表达与对照组相比均较低,且均发生明显高甲基化;去甲基化药物处理上述3株细胞株后,SOX30 mRNA的表达明显得到恢复。SOX30基因在大部分结直肠癌组织中均呈现高甲基化状态,甲基化发生率为79.6%(43/54);而在相应的癌旁组织中甲基化检出率较低,仅为20%(2/10)。对结直肠癌患者中SOX30基因甲基化与其临床病理学资料进行相关性分析发现,SOX30基因高甲基化与患者的肿瘤病理分型显著相关(P=0.045),而与患者的性别、年龄、吸烟与否、TNM分期和Ducks分期无显著相关性(P均>0.05)。结论:SOX30基因在结直肠癌中发生明显高甲基化修饰改变,其基因表达水平明显下调,而且其甲基化修饰率与患者肿瘤病理分型相关,提示SOX30可能在结直肠癌的发生过程中起重要作用。

关键词: SRY盒包含基因30, DNA甲基化, 结直肠癌, 甲基化特异性PCR, 硫化测序PCR

Abstract:

OBJECTIVE: To analyze the expression and methylation of SOX30 gene in colorectal cancer cell lines and colorectal cancer tissues. METHODS:The mRNA expression and methylation of SOX30 were evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and methylation specific PCR (MSP). Demethylation experiment with 5-Aza-CdR was used to confirm the regulation of SOX30 expression by DNA hypermethylation. The methylation of SOX30 was further confirmed by sodium bisulfite DNA sequencing (BSP). RESULTS:Hypermethylation of SOX30 gene was found in all the colorectal cancer cell lines, with reduced mRNA expression. The mRNA expression of SOX30 increased in colorectal cancer cell lines treated with 5-Aza-CdR, indicating that SOX30 expression was regulated by DNA methylation. SOX30 hypermethylation was found in most of the colorectal cancer tissues (79.6%) , but not in tumor adjacent tissues (20%). After investigating possible associations between SOX30 methylation and clinicopathologic features, we found that SOX30 hypermethylation was associated with histological type, but not correlated to gender, age, smoking, clinical TNM stages and Ducks stages. CONCLUSION:Down-regulation of SOX30 by hypermethylation was always found in colorectal cancer cell lines, and its hypermethylation was obviously associated with histological type, suggesting SOX30 playing an important role in the carcinogenesis of colorectal cancer.

Key words: SOX30, DNA methylation, colorectal cancer, methylation specific PCR, bisulfite squencing PCR

中图分类号: